Determinants of blood pressure control: a survey on Cilnidipine–Telmisartan use in uncontrolled hypertension
DOI:
https://doi.org/10.18203/2320-6012.ijrms20261073Keywords:
Cilnidipine, Telmisartan, Fixed-dose combination, Uncontrolled hypertension, Blood pressure control, AdherenceAbstract
Background: Uncontrolled hypertension remains a major public health challenge, often complicated by poor medication adherence and multiple comorbidities. Fixed-dose combinations such as Cilnidipine and Telmisartan (CILTEL) have been proposed to improve blood pressure (BP) control through complementary mechanisms and simplified dosing. Objectives were to assess physicians’ perceptions, attitudes, and prescribing patterns regarding CILTEL in the management of uncontrolled hypertension, and to identify factors associated with achieving ≥80% BP reduction.
Methods: A cross-sectional, questionnaire-based survey was conducted among 788 physicians across various regions and practice settings. Data were collected via structured personal interviews. Descriptive statistics summarized demographic and professional characteristics. Multivariate logistic regression identified independent predictors of achieving ≥80% BP reduction.
Results: The majority of physicians reported high satisfaction with CILTEL for patients with uncontrolled hypertension, citing improved BP control and better adherence as key benefits. Multivariate analysis revealed that good patient adherence (OR=1.91), absence of major comorbidities (OR=2.03), and longer duration of therapy (OR=1.83) were significant predictors of BP target achievement. Physicians also highlighted the convenience of a fixed-dose regimen in reducing pill burden and enhancing patient compliance.
Conclusions: CILTEL is perceived by physicians as an effective and well-tolerated option for uncontrolled hypertension, particularly when adherence is optimized and comorbidity burden is low. Its fixed-dose nature supports improved compliance, potentially translating into better long-term cardiovascular outcomes.
References
Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16(4):223-37. DOI: https://doi.org/10.1038/s41581-019-0244-2
Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. J Am Coll Cardiol. 2018;71(19):e127-248. DOI: https://doi.org/10.1016/j.jacc.2017.11.006
Mancia G, Rea F, Corrao G, Grassi G. Two decades of hypertension research: The evolution of guidelines and clinical practice. Eur Heart J Suppl. 2023;25(Suppl A):A3-13.
Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. J Am Coll Cardiol. 2019;74(10):e177-232. DOI: https://doi.org/10.1016/j.jacc.2019.03.010
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021-104. DOI: https://doi.org/10.1093/eurheartj/ehy439
Rakugi H, Enya K, Sugiura K, Ikeda Y. Comparison of telmisartan/cilnidipine and telmisartan/ hydrochlorothiazide combinations in hypertensive patients with type 2 diabetes mellitus: a randomized trial. Cardiovasc Diabetol. 2019;18:12.
Kayima J, Wanyenze RK, Katamba A, Leontsini E, Nuwaha F. Hypertension awareness, treatment and control in Africa: a systematic review. BMC Cardiovasc Disord. 2013;13:54. DOI: https://doi.org/10.1186/1471-2261-13-54
He J, Irazola V, Mills KT, Poggio R, Beratarrechea A, Dolan J, et al. Effect of a community health worker–led multicomponent intervention on blood pressure control in low-income patients in Argentina: a randomized clinical trial. JAMA. 2017;318(11):1016-25. DOI: https://doi.org/10.1001/jama.2017.11358
SPRINT Research Group, Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373(22):2103-16. DOI: https://doi.org/10.1056/NEJMoa1511939
Ataklte F, Erqou S, Kaptoge S, Taye B, Echouffo-Tcheugui JB, Kengne AP. Burden of undiagnosed hypertension in sub-Saharan Africa: a systematic review and meta-analysis. Hypertension. 2015;65(2):291-8. DOI: https://doi.org/10.1161/HYPERTENSIONAHA.114.04394
Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013;310(9):959-68. DOI: https://doi.org/10.1001/jama.2013.184182
Gupta R, Xavier D. Hypertension: The most important non-communicable disease risk factor in India. Indian Heart J. 2018;70(4):565-72. DOI: https://doi.org/10.1016/j.ihj.2018.02.003
Burnier M, Egan BM. Adherence in hypertension: a review of prevalence, risk factors, impact, and management. Circ Res. 2019;124(7):1124-40. DOI: https://doi.org/10.1161/CIRCRESAHA.118.313220
Anchala R, Kannuri NK, Pant H, Khan H, Franco OH, Di Angelantonio E, Prabhakaran D. Hypertension in India: a systematic review and meta-analysis of prevalence, awareness, and control of hypertension. J Hypertens. 2014;32(6):1170-7. DOI: https://doi.org/10.1097/HJH.0000000000000146
Bangalore S, Kamalakkannan G, Parkar S, Messerli FH. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med. 2007;120(8):713-9. DOI: https://doi.org/10.1016/j.amjmed.2006.08.033
Kario K, Sun N, Chiang FT, Supasyndh O, Baek SH, Inubushi-Molessa A, et al. Efficacy of a single-pill combination of cilnidipine and valsartan on blood pressure and microalbuminuria in Asian patients with hypertension. J Hypertens. 2019;37(3):655-64.
Geldsetzer P, Manne-Goehler J, Marcus ME, Ebert C, Zhumadilov Z, Wesseh CS, et al. The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1.1 million adults. Lancet. 2019;394(10199):652-62. DOI: https://doi.org/10.1016/S0140-6736(19)30955-9
Zhou B, Perel P, Mensah GA, Ezzati M. Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension. Nat Rev Cardiol. 2021;18(11):785-802. DOI: https://doi.org/10.1038/s41569-021-00559-8
Jafar TH, Gandhi M, de Silva HA, Jehan I, Naheed A, Finkelstein EA, et al; COBRA-BPS Study Group. A Community-Based Intervention for Managing Hypertension in Rural South Asia. N Engl J Med. 2020;382(8):717-26. DOI: https://doi.org/10.1056/NEJMoa1911965
Joseph P, Leong D, McKee M, Anand SS, Schwalm JD, Teo K, et al. Reducing the global burden of cardiovascular disease, part 1: the epidemiology and risk factors. Circ Res. 2017;121(6):677-94. DOI: https://doi.org/10.1161/CIRCRESAHA.117.308903
Downloads
Published
How to Cite
Issue
Section
